Avalo Therapeutics AVTX
NASDAQ AVTX
$15.33 -0.25 (-1.60%)
At close: Sep 30, 2026 · 4:00 PM EDT

Avalo Therapeutics (AVTX) Total Non-Current Liabilities (2015 - 2026)

Updated

Avalo Therapeutics (AVTX) reported Total Non-Current Liabilities of $23.59 million for Q2 2026, up 100.8% from $11.75 million a year earlier and up 68.0% from the prior quarter.

Analysis

Avalo Therapeutics (AVTX) Total Non-Current Liabilities (2015 - 2026) Analysis & Trends

At the end of FY2025, Avalo Therapeutics posted Total Non-Current Liabilities of $15.41 million, up 67.1% from FY2024.

  • Total Non-Current Liabilities has a five-year compound annual growth rate of -2.3% (FY2020 to FY2025).
  • By year, Total Non-Current Liabilities came in at $9.22 million in FY2024 (+13.3%), $8.14 million in FY2023 (-79.4%), $39.45 million in FY2022 (-28.1%) and $54.83 million in FY2021 (+216.7%).
  • The Q2 2026 figure ranks as the highest quarterly Total Non-Current Liabilities since Q3 2024.
  • Year over year, Total Non-Current Liabilities has now increased in each of the last three quarters, with growth averaging 70.5% over the last eight quarters.
  • The high point for year-over-year Total Non-Current Liabilities in five years was Q3 2024 (growth of 581.2%); the low point was Q1 2025 (a decline of 96.5%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $14.05 million (Q1 2026), $15.41 million (Q4 2025) and $10.39 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 105.99 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 106.45 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -967.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 5.92 Bn
10 Avalo Therapeutics 679.32 Mn 679.32 Mn - 23.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 23.59 Mn
Mar 31, 2026 14.05 Mn
Dec 31, 2025 15.41 Mn
Sep 30, 2025 10.39 Mn
Jun 30, 2025 11.75 Mn
Mar 31, 2025 8.17 Mn
Dec 31, 2024 9.22 Mn
Sep 30, 2024 65.57 Mn
Jun 30, 2024 111.21 Mn
Mar 31, 2024 230.60 Mn
Dec 31, 2023 8.14 Mn
Sep 30, 2023 9.63 Mn
Jun 30, 2023 26.15 Mn
Mar 31, 2023 37.49 Mn
Dec 31, 2022 39.45 Mn
Sep 30, 2022 36.78 Mn
Jun 30, 2022 36.24 Mn
Mar 31, 2022 53.20 Mn
Dec 31, 2021 54.83 Mn
Sep 30, 2021 53.65 Mn
API Access

Avalo Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=AVTX&period=max&api_key=YOUR_API_KEY